Catamaran's BriovaRx Receives URAC Specialty Pharmacy Accreditation

     Catamaran's BriovaRx Receives URAC Specialty Pharmacy Accreditation

PR Newswire

LISLE, IL, April 4, 2013

LISLE, IL, April 4, 2013 /PRNewswire/ -  Catamaran Corp. (NASDAQ: CTRX), (TSX:
CCT), a leading provider of pharmacy benefit management (PBM) services and
technology today announced that its specialty brand, BriovaRx™, has been
awarded Specialty Pharmacy Accreditation  from URAC, a Washington, D.C.-based
accrediting organization that establishes quality standards for the healthcare

"BriovaRx's robust offerings focus on the patient, ensuring one-on-one support
and a personalized plan that addresses chronic conditions to help them lead
healthy, vibrant lives," said Mark Thierer, Chairman and CEO of Catamaran.
"The URAC accreditation is a reflection of BriovaRx's patient-centric approach
that coordinates the efforts of providers, payers and manufacturers to keep
treatments personalized and successful."

Designed as a better alternative to other specialty pharmacy offerings,
BriovaRx is a high-touch, comprehensive care system of pharmacological care
where patients with chronic illnesses and complex diseases receive expert
therapy management and support tailored to their individual needs.

URAC made the decision to develop a Specialty Pharmacy accreditation program
because it is one of the key distribution channels for pharmacy benefit
management and extends URAC's consumer protection and empowerment efforts in
managed care pharmacy. URAC offers the only third-party, voluntary
accreditation program of this scope for pharmacy benefit management and
prescription services industry.

"The URAC accreditation is a recognition of the quality and broad scope of our
specialty pharmacy offering," said Albert Thigpen, Senior Vice President,
Pharmacy Operations of Catamaran. "As the fifth largest specialty pharmacy in
the nation, BriovaRx has the skill and scale to effectively manage costs for
health plans and other payers challenged by escalating specialty drug prices
and increased utilization. We look forward to continuing to deliver
personalized care and committed support to our patients."

"By applying for and receiving URAC accreditation, BriovaRx has demonstrated a
commitment to quality healthcare," said Alan P. Spielman, URAC president and
CEO. "Quality healthcare is crucial to our nation's welfare and it is
important to have organizations that are willing to measure themselves against
national standards and undergo rigorous evaluation by an independent
accrediting body."

About Catamaran
Catamaran, the industry's fastest-growing pharmacy benefit manager, helps
organizations and the communities they serve take control of prescription drug
costs. Managing more than 250 million prescriptions each year on behalf of 25
million members, our flexible, holistic solutions improve patient care and
empower individuals to take charge of their health. Processing one in every
five prescription claims in the U.S., Catamaran's skill and scale deliver
compelling financial results and sustainable improvement in the overall health
of members. Catamaran is headquartered in Lisle, Ill. with multiple locations
in the U.S. and Canada. For more information, please visit Follow us on Twitter @CatamaranCorp or

About URAC
URAC, an independent, nonprofit organization, is a leader in promoting health
care quality through accreditation and certification programs. URAC's
standards keep pace with the rapid changes in the health care system, and
provide a mark of distinction for health care organizations to demonstrate
their commitment to quality and accountability. Through its broad-based
governance structure and an inclusive standards development process, URAC
ensures that all stakeholders are represented in setting meaningful standards
for the health care industry. For more information, visit

SOURCE Catamaran


Tony Perkins
Investor Relations
Tel: (312) 261-7805
Press spacebar to pause and continue. Press esc to stop.